Table 3 Comparison between +ve HCV and −ve HCV patients as regards
Treatment modality | +ve HCV | −ve HCV | p-value | |||
|---|---|---|---|---|---|---|
No. | Percentage | No. | Percentage | |||
Anti-inflammatory | 5 | 3.1% | 158 | 96.9% | 1 | |
Steroid sparing | 4 | 4.5% | 84 | 95.5% | 0.373 | |
Biological | 3 | 15.0% | 17 | 85.0% | 0.013 | |
Steroids | 4 | 8.0% | 46 | 92.0% | 0.030 | |
Steroids details | No | 1 | 0.9% | 114 | 99.1% | 0.019 |
Once | 1 | 4.2% | 23 | 95.8% | ||
Repeated | 3 | 11.5% | 23 | 88.5% | ||